Cargando…

Influence of polyvascular disease on clinical outcome in patients undergoing transcatheter aortic valve implantation via transfemoral access

BACKGROUND: The influence of polyvascular disease (PVD) on the short- and long-term clinical outcomes of patients undergoing transcatheter aortic valve implantation via trans-femoral access (TF-TAVI) has not been fully elucidated. METHODS: A total of 2167 patients from the Optimized CathEter vAlvula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamawaki, Masahiro, Honda, Yosuke, Makino, Kenji, Nakano, Takahide, Iida, Yasunori, Yashima, Fumiaki, Ueno, Hiroshi, Mizutani, Kazuki, Tabata, Minoru, Tada, Norio, Takagi, Kensuke, Yamanaka, Futoshi, Naganuma, Toru, Watanabe, Yusuke, Yamamoto, Masanori, Shirai, Shinichi, Hayashida, Kentaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638934/ https://www.ncbi.nlm.nih.gov/pubmed/34855791 http://dx.doi.org/10.1371/journal.pone.0260385

Ejemplares similares

Small Left Ventricle and Clinical Outcomes After Transcatheter Aortic Valve Replacement
por: Saito, Tetsuya, et al.
Publicado: (2021)

Academic Research Consortium High Bleeding Risk Criteria associated with 2-year bleeding events and mortality after transcatheter aortic valve replacement discharge: a Japanese Multicentre Prospective OCEAN-TAVI Registry Study
por: Mizutani, Kazuki, et al.
Publicado: (2021)

Statin therapy for patients with aortic stenosis who underwent transcatheter aortic valve implantation: a report from a Japanese multicentre registry
por: Yashima, Fumiaki, et al.
Publicado: (2021)

Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement
por: Shimura, Tetsuro, et al.
Publicado: (2021)

Previously implanted mitral surgical prosthesis in patients undergoing transcatheter aortic valve implantation: Procedural outcome and morphologic assessment using multidetector computed tomography
por: Tanaka, Makoto, et al.
Publicado: (2019)

Prognostic Value of Ventricular‐Arterial Coupling After Transcatheter Aortic Valve Replacement on Midterm Clinical Outcomes
por: Yokoyama, Hiroaki, et al.
Publicado: (2021)

Patients’ characteristics and mortality in urgent/emergent/salvage transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry
por: Enta, Yusuke, et al.
Publicado: (2020)

Clinical risk model for predicting 1‐year mortality after transcatheter aortic valve replacement
por: Yamamoto, Masanori, et al.
Publicado: (2020)

Impact of beta blockers on patients undergoing transcatheter aortic valve replacement: the OCEAN-TAVI registry
por: Saito, Tetsuya, et al.
Publicado: (2020)

Predictors and clinical outcomes of poor symptomatic improvement after transcatheter aortic valve replacement
por: Yoshijima, Nobuhiro, et al.
Publicado: (2021)

Identification of Anemia for Predicting Mid-Term Prognosis After Transcatheter Aortic Valve Implantation in Japanese Patients　― Insights From the OCEAN-TAVI Registry ―
por: Onoda, Hiroshi, et al.
Publicado: (2021)

Elevation of B‐Type Natriuretic Peptide at Discharge is Associated With 2‐Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN‐TAVI (Optimized Transcatheter Valvular Intervention–Transcatheter Aortic Valve Implantation) Registry
por: Mizutani, Kazuki, et al.
Publicado: (2017)

Incidence, Timing, and Causes of Late Bleeding After TAVR in an Asian Cohort
por: Yamamoto, Masanori, et al.
Publicado: (2022)

Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve
por: Miyasaka, Masaki, et al.
Publicado: (2021)

Patients Refusing Transcatheter Aortic Valve Replacement Even Once Have Poorer Clinical Outcomes
por: Shimura, Tetsuro, et al.
Publicado: (2018)

Clinical Outcomes of Subcutaneous and Visceral Adipose Tissue Characteristics Assessed in Patients Underwent Transcatheter Aortic Valve Replacement
por: Shibata, Kenichi, et al.
Publicado: (2020)

Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in Japan
por: Mizutani, Kazuki, et al.
Publicado: (2018)

Prognostic impact of postprocedure stroke volume in patients with low-gradient aortic stenosis
por: Nara, Yugo, et al.
Publicado: (2019)

Comprehensive Assessment of Polyvascular Atherosclerosis
por: Nakanishi, Rine, et al.
Publicado: (2018)

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease
por: Tmoyan, Narek A., et al.
Publicado: (2021)

Transcatheter heart valve stuck in a surgical bioprosthesis during valve-in-valve transcatheter aortic valve replacement
por: Kawaguchi, Masanori, et al.
Publicado: (2023)

Transfemoral versus transcarotid access for transcatheter aortic valve replacement
por: Olivier, Maud-Emmanuelle, et al.
Publicado: (2022)

Polyvascular Disease and the Incidence of Cancer in Patients with Coronary Artery Disease
por: Suzuki, Makoto, et al.
Publicado: (2022)

Intensity of Lipid-Lowering Therapy Among Patients With Polyvascular Disease
por: Peterson, Benjamin E., et al.
Publicado: (2023)

Transfemoral transcatheter aortic valve implantation: towards local anaesthesia for everyone?
por: van Nieuwkerk, A. C., et al.
Publicado: (2022)

Operator Radiation Exposure During Transfemoral Transcatheter Aortic Valve Replacement
por: Goel, Sunny, et al.
Publicado: (2022)

Associations Between Polyvascular Disease and Stroke Recurrence in Patients With Lacunar Stroke
por: Ma, Lin, et al.
Publicado: (2021)

Preclinical carotid atherosclerosis as an indicator of polyvascular disease: a narrative review
por: Poredos, Pavel, et al.
Publicado: (2021)

Meta‐Analysis of Intensive Lipid‐Lowering Therapy in Patients With Polyvascular Disease
por: Alkhalil, Mohammad, et al.
Publicado: (2021)

Prognostic Role of Polyvascular Involvement in Patients with Symptomatic Peripheral Artery Disease
por: Adam, Luise, et al.
Publicado: (2023)

Preoperative Instrumental Activities of Daily Living Predicts Survival After Transcatheter Aortic Valve Implantation
por: Fukui, Shogo, et al.
Publicado: (2020)

MANTA closure device shows promise in transfemoral transcatheter aortic valve replacement
por: Vendrik, J., et al.
Publicado: (2020)

Point-of-Care Ultrasound Before and After Transfemoral Transcatheter Aortic Valve Implantation
por: Musuku, Sridhar Reddy, et al.
Publicado: (2020)

Comparison of transradial and transfemoral access for transcatheter arterial embolization of iatrogenic renal hemorrhage
por: Cao, Chuanwu, et al.
Publicado: (2021)

Predictive model for severe thrombocytopenia after transfemoral transcatheter aortic valve replacement
por: Li, Shaoman, et al.
Publicado: (2023)

Polyvascular Disease in Patients Presenting with Acute Coronary Syndrome: Its Predictors and Outcomes
por: Al Thani, Hassan, et al.
Publicado: (2012)

Changes of the eSheath Outer Dimensions Used for Transfemoral Transcatheter Aortic Valve Replacement
por: Koehler, Till, et al.
Publicado: (2015)

Inflammatory signatures are associated with increased mortality after transfemoral transcatheter aortic valve implantation
por: Hoffmann, Jedrzej, et al.
Publicado: (2020)

Comparative Outcomes of Transapical Versus Transfemoral Access for Transcatheter Aortic Valve Replacement in Diabetics
por: Elbadawi, Ayman, et al.
Publicado: (2019)

Transcatheter Aortic Valve Implantation: All Transfemoral? Update on Peripheral Vascular Access and Closure
por: Perrin, Nils, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_78abs46oi4hvdgsdj11m3nl74c